Funding · Company
Alpheus Medical, Inc.
Chanhassen, MNBiotech & Pharma
Alpheus Medical, Inc. of Chanhassen, MN has disclosed $60M across 1 Form D offering filed with the SEC on Jul 30, 2026.
$60M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$60M
Form D · Jul 30, 2026 ↗
Q3 2026
· 1 amendment, first filed May 19, 2025
· target $67M
Filing details
HeadquartersChanhassen, MNIndustryBiotech & Pharma (Biotechnology)SEC CIK0001716636Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →